Search research articles
Contact Us
Filters
Showing results (201-210 of 274) with videos related to
Page
of 28
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 27, 2021
Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
Theodoros Michelakos, Yurie Sekigami, Filippos Kontos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 12, 2025
Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
Grace Lee, Bailey Nelson, Julie Koenig, et al.
Cancer Medicine
|
May 18, 2018
Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis
Sophia C Kamran, Jeffrey W Clark, Hui Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2019
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study
Jennifer Y Wo, John P Plastaras, James M Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.
Practical Radiation Oncology
|
June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control
Jennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Annals of Surgical Oncology
|
August 3, 2020
Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
Edward Christopher Dee, Morgan E Freret, Nora Horick, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2019
Clinical impact of PET/MR in treated colorectal cancer patients
Barbara J Amorim, Theodore S Hong, Lawrence S Blaszkowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
Joseph P Eder, Jeffrey G Supko, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2023
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer
Yves Boucher, Jessica M Posada, Sonu Subudhi, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 274) with videos related to
Sort By:
Page
of 28
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 27, 2021
Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
Theodoros Michelakos, Yurie Sekigami, Filippos Kontos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 12, 2025
Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
Grace Lee, Bailey Nelson, Julie Koenig, et al.
Cancer Medicine
|
May 18, 2018
Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis
Sophia C Kamran, Jeffrey W Clark, Hui Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2019
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study
Jennifer Y Wo, John P Plastaras, James M Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer
Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, et al.
Practical Radiation Oncology
|
June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control
Jennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Annals of Surgical Oncology
|
August 3, 2020
Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
Edward Christopher Dee, Morgan E Freret, Nora Horick, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 31, 2019
Clinical impact of PET/MR in treated colorectal cancer patients
Barbara J Amorim, Theodore S Hong, Lawrence S Blaszkowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
Joseph P Eder, Jeffrey G Supko, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2023
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer
Yves Boucher, Jessica M Posada, Sonu Subudhi, et al.
Page
of 28